Dendreon (DNDN) Will Seek FDA Provenge Approval In Mid-November
Tweet Send to a Friend
At an analyst meeting, Dendreon Corp (Nasdaq: DNDN) said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
